Trumenba
NDC 0005-0100, meningococcal group B vaccine, injection, suspension, from Wyeth Pharmaceutical Division of Wyeth Holdings LLC.
- Product NDC
- 0005-0100
- Status
- Listed
- Labeler
- Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125549
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0005-0100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN60 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN60 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0005-0100-05 | 00005010005 | 5 SYRINGE in 1 CARTON (0005-0100-05) / .5 mL in 1 SYRINGE (0005-0100-01) |
| 0005-0100-10 | 00005010010 | 10 SYRINGE in 1 CARTON (0005-0100-10) / .5 mL in 1 SYRINGE (0005-0100-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0005-0100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0005-0100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0005-0100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.